Clinical Trial Update: Cardiovascular Risk Evaluation in Clinical Practice in Metabolic Syndrome Patients

View source ↗

Summary

A completed clinical trial update evaluating cardiovascular risk assessment in patients with metabolic syndrome, sponsored by Novartis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Snippet

Sponsor: Novartis | Conditions: Metabolic Syndrome | Status: COMPLETED